Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Bacillus Subtilis in Parkinson's Disease [NA]
A completed clinical trial in Parkinson disease investigating Bacillus subtilis, reported by the University of Edinburgh.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Investigating Adaptive Deep Brain Stimulation in Parkinson's Disease Management [NA]
A clinical trial update indicates that adaptive deep brain stimulation for Parkinson's disease management is not yet recruiting, sponsored b…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Etoricoxib in Patients With Parkinsonian Disease [Phase 2]
Phase 2 trial update for etoricoxib in Parkinson disease; the study is currently recruiting.
-
CLINICAL_TRIALS other · 2026-04-08Clinical Trial Update: Udall Project 1 Aim 4
Udall Project 1 Aim 4 is currently recruiting for a Parkinson's disease study that involves deep brain stimulation.
-
EMA approval · 2026-04-07EMA Authorised: Neupro (rotigotine) — UCB Pharma S.A.
The EMA has authorised Neupro (rotigotine) by UCB Pharma S.A. for Restless legs syndrome and Parkinson's disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Telemedicine Intervention in Patients With Chronic Pain in PD [NA]
A clinical trial update describes an ongoing telemedicine intervention study for chronic pain in Parkinson's disease, currently active but n…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcutaneous Foslevodopa/Foscarbidopa in Belgium
A Belgium-based clinical trial recruiting adults with advanced Parkinson's disease to evaluate changes in disease symptoms after subcutaneou…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD) [Phase 1]
Phase 1 trial evaluating Lu AF28996 in Parkinson's disease. The study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations [Phase 2]
This is a Phase 2 clinical trial update evaluating Lu AF28996 in adults with Parkinson's disease who have motor fluctuations. The study stat…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of Buntanetap in Participants With PD [Phase 2, Phase 3]
Clinical trial update for Buntanetap in Parkinson's disease, including patients with deep brain stimulation; the study is in Phase 2/3 and c…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Adapting rHIRE and Sleep Monitoring in Parkinson's Disease [NA]
A clinical trial update from the University of Colorado, Denver on adapting rHIRE and sleep monitoring for Parkinson's disease; the study is…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: CPAP for the Treatment of Supine Hypertension [NA]
This clinical trial update indicates that a study is recruiting to evaluate CPAP for the treatment of supine hypertension in autonomic failu…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Physiological Investigations of Movement Disorders [NA]
Completed status update for a National Institute of Neurological Disorders and Stroke study investigating physiological aspects of movement …
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease [Phase 2]
Phase 2 study evaluating UCB0022 in advanced Parkinson's disease has completed, with data assessing efficacy, safety, tolerability, and phar…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease [Phase 2]
Phase 2 clinical trial conducted at University Hospital, Toulouse, evaluating amantadine for L-DOPA-induced dyskinesia in early Parkinson's …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Low Voltage Electrical Stimulation for Depression in Parkinson's Patients [NA]
This clinical trial update reports that a study investigating low voltage electrical stimulation to treat depressive symptoms in Parkinson's…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: The Swedish BioFINDER 2 Study [NA]
This is a status update for the Swedish BioFINDER 2 study, which is currently recruiting participants for research on various neurodegenerat…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Imaging Biomarkers in Parkinson s Disease
This update notes that the NINDS-funded imaging biomarkers trial in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations
NHGRI-sponsored clinical trial evaluating positron emission tomography imaging in people with Gaucher mutations (including those with Parkin…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations [Phase 2]
A Phase 2 clinical trial is evaluating two doses of AP-472 as an add-on to levodopa in Parkinson disease patients with motor fluctuations, a…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease [Phase 4]
This ClinicalTrials.gov entry updates a Phase 4 study evaluating behavioral interventions and/or mirabegron to treat urinary symptoms in Par…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
An ongoing prospective study evaluating radiofrequency ablation for central nervous system targets in Parkinson disease, dystonia, and essen…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease [Phase 3]
Roche's Phase 3 trial is evaluating intravenous prasinezumab for early-stage Parkinson's disease and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Testing of an Interface for Synchronizing tACS-DBS With a Phase-locked-loop [NA]
A clinical trial update describes testing an interface to synchronize transcranial alternating current stimulation with deep brain stimulati…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders [NA]
Clinical trial update for a study of Ultra-High Resolution PET imaging in aging, neurodegeneration and psychotic disorders; recruitment is o…